key: cord-0858710-6lfzth0c
authors: Mishra, Ajay Kumar; Sahu, Kamal Kant; Lal, Amos; Sargent, Jennifer
title: Patterns of heart Injury in COVID – 19 and relation to outcome
date: 2020-04-08
journal: J Med Virol
DOI: 10.1002/jmv.25847
sha: 263325c7c9b26dec61013e8b5ecfe31be340e82f
doc_id: 858710
cord_uid: 6lfzth0c

We read with much interest the article “Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China” by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK‐MB, Myoglobulin, cardiac troponin I (cTnI) and NT‐ proBNP on the outcome of 273 patients with COVID‐19 disease. This article is protected by copyright. All rights reserved.

acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT-proBNP on the outcome of 273 patients with COVID-19 disease. Authors have suggested that elevated concentrations of these enzymes in venous blood were related to disease severity and poor outcome 1 . We believe that this topic is relevant and evolving. We have the following additional comments for further understanding of the disease and its various pathophysiological bases in cardiac involvement.

Non ischemic and ischemic myocardial injury has been attributed to be the two principle 

Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol

Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation. 0(0)

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

Update on 3rd

Coronavirus Outbreak of 21st Century

COVID-19 and the cardiovascular system

The Clinical Characteristics of Myocardial injury in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease